These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35486375)

  • 21. Autologous Micrografts from Scalp Tissue: Trichoscopic and Long-Term Clinical Evaluation in Male and Female Androgenetic Alopecia.
    Gentile P; Scioli MG; Cervelli V; Orlandi A; Garcovich S
    Biomed Res Int; 2020; 2020():7397162. PubMed ID: 32071919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
    Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM
    JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
    Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M
    J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anagen effluvium.
    Kanwar AJ; Narang T
    Indian J Dermatol Venereol Leprol; 2013; 79(5):604-12. PubMed ID: 23974578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous Cellular Method Using Micrografts of Human Adipose Tissue Derived Follicle Stem Cells in Androgenic Alopecia.
    Gentile P
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31337037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.
    Aryanian Z; Balighi K; Hatami P; Afshar ZM; Mohandesi NA
    Dermatol Ther; 2022 Jun; 35(6):e15433. PubMed ID: 35266262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the safety and efficacy of platelet-rich plasma in the treatment of female patients with chronic telogen effluvium: A randomised, controlled, double-blind, pilot clinical trial.
    El-Dawla RE; Abdelhaleem M; Abdelhamed A
    Indian J Dermatol Venereol Leprol; 2023; 89(2):195-203. PubMed ID: 35593290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriatic alopecia.
    George SM; Taylor MR; Farrant PB
    Clin Exp Dermatol; 2015 Oct; 40(7):717-21. PubMed ID: 26202646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study.
    Awad NEHA; Obaid ZM; Zaky MS; Elsaie ML
    Ir J Med Sci; 2024 Apr; 193(2):761-767. PubMed ID: 37704885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telogen Effluvium With Dysesthesia (TED) Has Lower B12 Levels and May Respond to B12 Supplementation.
    Daly T; Daly K
    J Drugs Dermatol; 2018 Nov; 17(11):1236-1240. PubMed ID: 30500148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.
    Bedair NI; Abdelaziz AS; Abdelrazik FS; El-Kassas M; AbouHadeed MH
    Arch Dermatol Res; 2024 Jun; 316(6):336. PubMed ID: 38844670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of Mast Cells and Mast Cell Degranulation in Scalp Biopsies of Telogen Effluvium.
    Grace SA; Sutton AM; Abraham N; Armbrecht ES; Vidal CI
    Int J Trichology; 2017; 9(1):25-29. PubMed ID: 28761261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Red nail bands in conjunction with telogen effluvium as a post-COVID-19 phenomenon.
    Thakur V; Bisht YS; Sethi S; Jindal R
    Australas J Dermatol; 2022 Feb; 63(1):141-142. PubMed ID: 34958136
    [No Abstract]   [Full Text] [Related]  

  • 35. Localized Telogen Effluvium Following Hair Transplantation.
    Loh SH; Lew BL; Sim WY
    Ann Dermatol; 2018 Apr; 30(2):214-217. PubMed ID: 29606820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies.
    Weng CT; Wei KC; Yang CC
    Influenza Other Respir Viruses; 2024 Jul; 18(7):e13356. PubMed ID: 39057605
    [No Abstract]   [Full Text] [Related]  

  • 37. Telogen Effluvium - a review of the science and current obstacles.
    Chien Yin GO; Siong-See JL; Wang ECE
    J Dermatol Sci; 2021 Mar; 101(3):156-163. PubMed ID: 33541773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia.
    Guarnieri G; Bertagna De Marchi L; Marcon A; Panunzi S; Batani V; Caminati M; Furci F; Senna G; Alaibac M; Vianello A
    Ann Med; 2022 Dec; 54(1):869-874. PubMed ID: 35341398
    [No Abstract]   [Full Text] [Related]  

  • 39. Characteristics of telogen effluvium in COVID-19 in western Iran (2020).
    Babaei K; Kavoussi H; Rezaei M; Kavoussi R
    An Bras Dermatol; 2021; 96(6):688-692. PubMed ID: 34593265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of hair loss after COVID-19: A systematic scoping review.
    Czech T; Sugihara S; Nishimura Y
    J Cosmet Dermatol; 2022 Sep; 21(9):3655-3662. PubMed ID: 35801366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.